TL;DR: Steris invented vaporized hydrogen peroxide (VHP) technology and built it for pharmaceutical-grade sterility validation. PuroGen applies VHP specifically to cannabis operations, with cannabis-specific throughput, regulatory documentation, and compliance support. Choosing between them is ultimately a question of what your operation needs: a platform built for pharma that can be adapted to cannabis, or a system purpose-built for the cannabis regulatory environment from the ground up.
Key Takeaways
- Steris is the originator and trademark holder of VHP® technology, with decades of pharmaceutical validation data
- PuroGen builds on the same core VHP science with hardware and documentation designed specifically for cannabis operations
- Key differentiation dimensions: throughput scale, compliance documentation format, cannabis-specific regulatory expertise, and total cost of ownership
- Both platforms use non-condensing hydrogen peroxide vapor that breaks down to water and oxygen—the core science is shared
- Pharmaceutical validation packages from Steris may not map directly to cannabis regulatory documentation requirements
- PuroGen's cannabis-specific positioning includes OLCC-compatible documentation outputs and Oregon-aware compliance support
Understanding VHP Technology Origins
Vaporized hydrogen peroxide is not a new technology. Steris Corporation pioneered and trademarked the VHP® process in the late 1980s, developing it initially for pharmaceutical cleanroom decontamination, sterile manufacturing environments, and hospital infection control.
The core principle is consistent across all VHP applications: hydrogen peroxide is heated and vaporized into a submicron aerosol—particles small enough to penetrate porous materials, reach all surfaces within a treatment space, and achieve validated microbial kill without leaving toxic residue. When the cycle completes, hydrogen peroxide catalytically decomposes to water vapor and oxygen. There is no chemical residue, no off-gassing concern, and no material compatibility issues with electronics, textiles, or sensitive instrumentation.
This is the key advantage VHP has over alternative decontamination methods like ozone generators, UV irradiation, chemical foggers, and gamma irradiation—each of which involves significant trade-offs in either efficacy, material compatibility, regulatory acceptance, or residue concerns.
Understanding that both Steris and PuroGen are delivering the same core scientific mechanism matters for the comparison that follows. The differentiation is not in the chemistry—it is in how that chemistry is packaged, validated, documented, and supported for the specific context of cannabis operations.
Steris: Pharmaceutical-Grade Heritage
Steris's VHP technology was built to meet the most demanding sterilization and decontamination requirements in regulated industry: FDA-inspected pharmaceutical manufacturing facilities, sterile compounding pharmacies, hospital isolation units, and research containment environments.
What Steris Does Well
Extensive validation data. Decades of pharmaceutical use means Steris has validation packages—biological indicator studies, cycle development data, surface contact efficacy tests—that have been reviewed and accepted by FDA inspectors. For operations that need to demonstrate validated sterility assurance to the strictest possible standard, this documentation heritage is a meaningful advantage.
Large-scale and fixed-installation systems. Steris's commercial VHP platforms are engineered for large-scale deployments: manufacturing suites, cleanrooms, and multi-room facilities where cycle times and generator capacity must be precisely matched to space volume. If a cannabis operation has a very large processing facility and needs to decontaminate entire production zones, Steris's large-footprint systems are designed for that environment.
Broad material compatibility testing. Because Steris systems have been deployed across pharmaceutical, aerospace, and defense applications, the material compatibility database is extensive—covering alloys, polymers, textiles, electronics, and specialty materials that may not commonly appear in cannabis processing environments.
Regulatory acceptance in pharmaceutical context. Steris's validation documentation is formatted to meet FDA, EMA, and ISO pharmaceutical standards. For operations with dual-use requirements—cannabis and pharmaceutical or nutraceutical production—having Steris validation packages on file may simplify certain cross-regulatory documentation needs.
Where Steris Has Limitations for Cannabis Operations
Pharmaceutical documentation ≠ cannabis compliance documentation. Oregon's OLCC remediation framework, California's BCC requirements, and state cannabis compliance audits are structured very differently from FDA pharmaceutical inspections. Steris's validation packages are formatted for pharma—the language, the structure, and the reference standards are oriented toward FDA compliance, not state cannabis agency review. Translating a Steris validation package into documentation that directly satisfies an OLCC audit question requires additional work.
Cannabis-specific regulatory expertise. Steris's sales and support infrastructure is oriented toward pharmaceutical, healthcare, and life sciences customers. Cannabis-specific knowledge—Oregon's reanalysis windows, Metrc documentation requirements, state-by-state remediation rule differences—is not a core competency of Steris's commercial support function.
Cost structure for smaller operations. Steris's industrial-scale systems are priced for large pharmaceutical and manufacturing deployments. The total cost of ownership—equipment, installation, validation, and ongoing service contracts—can be prohibitive for cannabis operations at craft or mid-scale sizes.
PuroGen: Cannabis-Specific Application
PuroGen builds on the same core VHP science Steris pioneered and applies it specifically to cannabis processing operations. The hardware design, documentation infrastructure, and support model are developed around the practical realities of cannabis compliance: state-by-state rule variation, Metrc integration, audit-readiness, and the operational cadence of licensed processors.
What PuroGen Does Well
Purpose-built for cannabis throughput. PuroGen's system design targets the operational scales common in cannabis processing: batch sizes from a few pounds to hundreds of pounds, cycle times compatible with production schedules, and form factors that fit within licensed cannabis facility footprints. The system is not a pharmaceutical cleanroom tool adapted for cannabis—it is engineered for cannabis processing from the ground up.
Cannabis-specific compliance documentation. PuroGen's documentation outputs are structured to support cannabis regulatory review directly—not translated from pharmaceutical standards. Cycle logs, parameter records, and validation summaries are formatted to align with what state cannabis compliance auditors actually request and review. For Oregon operations, this includes documentation structured around OLCC's audit expectations for remediation records.
State-aware regulatory support. Cannabis regulations vary significantly by state, and they change frequently. PuroGen's support team carries specific knowledge of cannabis regulatory requirements—Oregon's OLCC framework, California's BCC documentation standards, and how VHP fits within each state's explicitly approved or recognized remediation methods. This is expertise that a Steris industrial sales team is not structured to provide.
Lower cost of ownership at cannabis scale. Because PuroGen's systems are designed for cannabis facility sizes rather than pharmaceutical cleanroom scales, the capital cost, installation requirements, and ongoing maintenance burden are calibrated to the economics of licensed cannabis operations rather than large-scale pharmaceutical manufacturing.
Remediation workflow integration. PuroGen positions VHP not just as a post-failure remediation tool but as an in-process control step—a proactive intervention that reduces microbial load before testing, which supports compliance efficiency rather than just failure recovery. This workflow positioning aligns with how Oregon's framework allows VHP to serve as a preventive step for processors whose product is destined for extraction.
Where PuroGen Has Limitations
Less pharmaceutical validation history. Because PuroGen is a newer, cannabis-specific platform, the accumulated validation data history does not match Steris's decades of pharmaceutical documentation. For operations with strong pharmaceutical-industry backgrounds that prioritize legacy validation packages, this is a consideration.
Smaller footprint systems. PuroGen's current platform range is optimized for cannabis facility scales. Very large-scale operations—multi-thousand square foot production zones or commercial extraction facilities of pharmaceutical dimensions—may require system configurations that exceed PuroGen's current standard offerings.
Feature Comparison
| Dimension | Steris | PuroGen | |---|---|---| | Technology origin | Originator and trademark holder of VHP® | Cannabis-specific VHP application | | Validation data heritage | Decades of pharmaceutical documentation | Cannabis-focused validation development | | Documentation format | FDA/pharmaceutical compliance orientation | Cannabis compliance orientation | | Cannabis regulatory expertise | General support team | Cannabis-specific regulatory knowledge | | Scale range | Large to industrial scale | Cannabis facility scale | | Cost of ownership | Higher (pharmaceutical market pricing) | Calibrated to cannabis operations | | Metrc-compatible documentation | Requires adaptation | Structured for cannabis compliance | | Material compatibility | Extensive pharma/industrial database | Cannabis processing environment focus | | In-process control positioning | Available but not the primary use case | Core positioning for cannabis operators |
Which Solution Fits Which Operation
The right choice depends on your operation's specific profile.
Consider Steris if:
- Your operation is dual-use (cannabis and pharmaceutical or nutraceutical)
- You have a large-scale facility where industrial VHP systems are the appropriate fit
- Your compliance team has pharmaceutical regulatory experience and can translate pharma validation packages
- You need to demonstrate sterility assurance to FDA standards in addition to state cannabis agency requirements
Consider PuroGen if:
- Your operation is cannabis-focused and state-regulated
- You need documentation that directly satisfies OLCC, BCC, or comparable state cannabis compliance review
- You want cannabis-specific regulatory support from a team that understands Oregon's reanalysis windows, Metrc logging, and state audit expectations
- Your facility size and economics align better with cannabis-scaled equipment and pricing
For most Oregon-licensed processors, the practical answer is PuroGen: the documentation structure, regulatory expertise, and economic profile are better matched to cannabis operational realities. The pharmaceutical heritage of Steris's platform is genuinely valuable—but that value is most accessible to operations with the resources and expertise to bridge between pharmaceutical and cannabis regulatory frameworks.
Integration Considerations
Regardless of which VHP platform an operation selects, successful deployment requires attention to several integration factors that are independent of brand choice.
Space and airflow. VHP works through vapor distribution, which means room geometry, HVAC configuration, and any obstacles to vapor circulation all affect cycle efficacy. Proper deployment requires a site assessment to confirm that the chosen system's output matches the treatment space's volume and geometry.
Cycle development and validation. A validated VHP process is not the same as a VHP system that runs a cycle. Validation requires biological indicator studies, challenge testing, and documented evidence that the cycle achieves the target log reduction under worst-case conditions. Both Steris and PuroGen offer cycle development support, but operators should confirm what validation deliverables are included in the deployment scope.
Operator training. VHP is a validated process. Consistent outcomes depend on trained operators who follow the defined cycle protocol precisely. Both platforms should include operator training as part of deployment. Documentation of operator training is itself an audit-relevant record in cannabis compliance frameworks.
Ongoing cycle monitoring. Post-deployment, maintaining cycle log records is not optional—it is the audit trail that demonstrates consistent process control. Both Steris and PuroGen generate cycle data logs; confirming that those logs are formatted for cannabis compliance documentation purposes, not just internal process records, is an important deployment consideration.
Frequently Asked Questions
Is PuroGen the same technology as Steris VHP®?
PuroGen applies the same vaporized hydrogen peroxide chemistry that Steris pioneered. The core mechanism—submicron H₂O₂ vapor that decomposes to water and oxygen after contact—is consistent across all VHP applications. The difference is in how the technology is packaged, scaled, validated, and documented for the specific context of cannabis operations.
Does Steris VHP meet Oregon's remediation requirements?
Oregon's rules recognize sterilization processes as a compliant remediation method for microbial failures but do not specify particular commercial platforms. A VHP system from any manufacturer could qualify—what matters is validation that demonstrates effective microbial kill, proper documentation of the remediation cycle, and correct logging in Metrc. Steris documentation formatted for pharmaceutical compliance would need to be translated for Oregon audit purposes.
What is the typical ROI timeline for a VHP sterilization system in cannabis?
The ROI calculation depends heavily on failure rates, batch values, and current remediation costs. A useful framework: if a processor is discarding or losing margin on even one or two batches per quarter due to microbial failures, the annual cost of those losses frequently exceeds the annualized cost of VHP infrastructure. Oregon's "effective sterilization" carve-out for processors making concentrates or extracts adds a secondary ROI dimension through avoided test cycles.
Can VHP be used as a preventive step, not just post-failure remediation?
Yes—and this is an important framing distinction. Oregon's rules recognize VHP as a legitimate in-process step for flower destined for extraction, which means it can reduce microbial load before testing rather than only after a failure. This shifts VHP from a cost center (failure recovery) to a compliance infrastructure investment (test cycle efficiency). PuroGen specifically positions this workflow; Steris deployments can achieve the same outcome but may require more operator-side workflow design to implement it.
What should cannabis operators ask during a VHP system procurement conversation?
Key questions: What validation documentation does the deployment package include, and is it formatted for cannabis compliance review? What cycle development support is included? What does a standard treatment cycle log look like, and can they provide an example? What is the service and calibration schedule, and what does it cost? What regulatory expertise does the support team have for your specific state's compliance framework?